PALM BEACH, Fla., Oct. 21, 2019 – The Now Corporation (OTC: NWPN), A Bio-Pharmaceutical Research Company focused on the Research, Education and Production of Scientific-Grade Cannabidiol and Tetrahydrocannabinol medicine, is pleased to announce its newly appointed Directors and Senior Research Advisor: Mr. Brian Martin, Mr. Juan Salazar, Mr. Augustus Redmond, Mr. Kenneth Williams and Mr. Jeffrey Martin, and Senior Corporate Research Advisor, Dr. David Krolewski, Ph.D.
Dr. David Krolewski is a systems neuroscientist with a particular interest in neuroanatomical function pertaining to human health and disease. This arena of study allows for analysis of particular molecules that affect brain function in relation to behavioral outcomes. After receiving a B.S. from Grand Valley State University in Health Science, he worked as a research technician at the Ann Arbor Veteran’s hospital where he assessed neurotransmitter transporter abundance in postmortem brain of people who died due to cocaine abuse. Following this experience, David went on to obtain a Ph.D. from Wayne State University Medical School where his research focused on Parkinson’s disease models and related neurocircuitry which regulate motor activity and its coordination. David’s postdoctoral fellowship was completed at the University of Michigan Medical School and involved the investigation of neuronal gene expression in postmortem subjects previously diagnosed with psychiatric disorders including major depression, bipolar disorder, and schizophrenia. Advancing to a research faculty member at the University of Michigan Medical School, he co-instructed an undergraduate human neuroanatomy course and continued examining neurogenetic changes in psychiatric illness by optimizing cutting edge histological techniques to visualize and quantify molecular changes in 3-dimensional formats.
Brian Martin, Managing Director, Advanced Technology Research Innovations, will focus on innovation, either by studying and developing new technologies or by innovating engineering tools and methodologies for Research. He graduated from Michigan State University with an emphasis in Biochemistry, Molecular Biology and BioTechnology.
Juan Salazar, Managing Director, Engineering Operations, over the course of his career, Mr. Salazar has held senior and executive management positions with leading engineering, construction and development companies. He has a proven track record both at an operating and advisory level as a project manager, covering all stages of a construction from feasibility and engineering projects including technical reviews, project and financial evaluations to strategic planning, development, housing expansion, risk assessments and due diligence. In addition, he has extensive experience in agriculture and fish aquaponics and formed a Florida-based corporation named, Zorhek Aqua Farms.
Mr. Augustus Redmond, Managing Director, Business and Economic Developer, over 35 years experience in Real Estate, Retailing, and Wholesale Industries. He has deep experience identifying and directing public/private joint ventures that are consistent with community objectives, including RFP solicitations, new initiatives, and revitalization efforts. He has extensive National and International experience building rapport with businesses, property owners and real estate brokers, including the President and CEO of Global Mortgage Company, an Illinois Residential Mortgage Licensee and Gary Hope 6 Housing Department. Presently, Mr. Redmond is one of three volunteers with the Infinite Scholars Program for Corporate Sponsorship for the Chicago Chapter’s Youth.
Mr. Jeff Martin, Managing Director, Technology Director, has 40 years of marketing, management and operational experience in a wide range of industries including management consulting and design engineering. He has held senior management positions in small private companies and large ($400 M+) publicly held enterprises. He has demonstrated success implementing innovative technology solutions to create growth opportunities and improve productivity. Mr. Martin holds an MBA from Northwestern University, a BS in Electrical Engineering and an MS in Nuclear Engineering from the University of Illinois.
Ken Williams, CEO and Managing Director, also serves as Brand and Marketing Strategist. After spending five years leading public companies in the Legal Marijuana Industry, three decades of Advanced Technology Engineering, and as an Executive for multimillion dollar brands, Ken knows what truly drives business. It’s how well you connect with the public to help and communicate for understanding. Ken has excellent strategic planning and corporate execution skills. He works with major financial providers and bank brokerage firms on strategic initiatives including planning, clearing decisions, corporate changes and providers, and execute on new business opportunities.
Ken Williams, CEO of The Now Corporation (OTC:NWPN), states, “Our vision is to develop a constant, safe and quality medicine within the pharmaceutical market, creating an opioid alternative drug for humans and animals, as well as creating improved patient experiences, and clear choices. The Now Corporation is approaching a wide variety of markets including, but not limited to, Human / Animal CBD Medicine, Biofuel derived from Industrial Hemp, Raw Hemp for Textile and numerous other products developed from Hemp. The research is an important starting place for The Now Corporation as we expand into other applications. The Now Corporation will describe specific projects at the appropriate time.”
The Now Corporation’s overall business approach revolves around building a dynamic and highly opportunistic public company that serves the fast growing cannabinoid industry across the US and Canada. By providing Credible Scientific Research Data to the heavily regulated medical and recreational marijuana industries, we are dedicated to advancing the study of the medicinal use of cannabidiol and other cannabinoids. To achieve this, we look to employ advanced technologies to elucidate the biological underpinnings of specific mechanisms utilized by these molecules to potentially alter behavioral responses and various physiological processes. These findings will greatly advance the understanding of how cannabinoids affect genetic regulation, molecular signaling, and overall cellular function across multiple mammalian organ systems.
The Now Corporation (OTC: NWPN) is a publicly traded, bio-pharmaceutical research company focused on the research, education and production of Scientific-Grade Cannabidiol (CBD) from hemp and Tetrahydrocannabinol (THC) to be used for medicinal purpose, while focusing on pursuing business opportunities in the growing medical and recreational marijuana sector. Through its acquired assets, The Now Corporation is seeking to invest in our businesses associated with the growing, marketing, research and development, training, distribution and retail sale of scientific-grade medicinal cannabis, both in the United States and Canada. At The Now Corporation, we unlock and advance medicine for human life around the world, at every stage of life.
For further information, please contact:
Chief Executive Officer
The Now Corporation
Phone: (561) 318-1903
Legal Notice Regarding Forward-Looking Statements:
This press release contains forward-looking information within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and is subject to the safe harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. That includes the possibility that the business outlined in this press release cannot be concluded for some reason. That could be as a result of technical, installation, permitting or other problems that were not anticipated. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of The Now Corporation to be materially different from the statements made herein. Except for any obligation under the U.S. federal securities laws, The Now Corporation undertakes no obligation to publicly update any forward-looking statement as a result of new information, future events or otherwise.